| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Jaeger™ Medical, a global leader in respiratory diagnostic products, is pleased to announce a strategic partnership with Pulmonx Corporation, Redwood City, California, USA, to integrate advanced data qualification functionality into SentrySuite™, the Jaeger™ Medical industry-leading software platform for respiratory diagnostics.
The partnership enables direct incorporation of intelligent data validation and qualification logic into SentrySuite™, enhancing the platform's ability to support consistent and high-quality clinical decision-making. This integration empowers healthcare providers to more easily identify patients with secondary findings, such as severe hyperinflation secondary to emphysema, that may qualify them for innovative new treatments such as the Zephyr Valve. It also enables them to integrate those findings seamlessly into their diagnostic workflow.
Posted In: LUNG
